{"organizations": [], "uuid": "837ba04bce75e85d1c4e9450f6391fcd1da02617", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biocryst-announces-initiation-of-a/brief-biocryst-announces-initiation-of-apex-s-long-term-safety-trial-of-bcx7353-in-patients-with-hereditary-angioedema-idUSFWN1QI0UP", "country": "US", "domain_rank": 408, "title": "BRIEF-BioCryst Announces Initiation Of APeX-S Long-Term Safety Trial Of BCX7353 In Patients With Hereditary Angioedema", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.145, "site_type": "news", "published": "2018-02-28T19:15:00.000+02:00", "replies_count": 0, "uuid": "837ba04bce75e85d1c4e9450f6391fcd1da02617"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biocryst-announces-initiation-of-a/brief-biocryst-announces-initiation-of-apex-s-long-term-safety-trial-of-bcx7353-in-patients-with-hereditary-angioedema-idUSFWN1QI0UP", "ord_in_thread": 0, "title": "BRIEF-BioCryst Announces Initiation Of APeX-S Long-Term Safety Trial Of BCX7353 In Patients With Hereditary Angioedema", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biocryst pharmaceuticals inc", "sentiment": "negative"}, {"name": "biocryst", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Biocryst Pharmaceuticals Inc:\n* BIOCRYST ANNOUNCES INITIATION OF THE APEX-S LONG-TERM SAFETY TRIAL OF BCX7353 IN PATIENTS WITH HEREDITARY ANGIOEDEMA Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T19:15:00.000+02:00", "crawled": "2018-03-01T21:01:01.024+02:00", "highlightTitle": ""}